Dysfunction of FoxO1 pathways results in several metabolic diseases, including diabetes, obesity, non-alcoholic fatty liver disease, and atherosclerosis. This evidence concerns the gene FOXO1 and metabolic dysfunction-associated steatotic liver disease.